Related Experiment Videos
Intracranial Wegener's granulomatosis
L M Weinberger1, M L Cohen, B F Remler
1Department of Neurology, University Hospitals of Cleveland, OH.
Neurology
|September 1, 1993
Summary
Wegener's granulomatosis (WG) can present atypically with brain and meningeal involvement. Early immunosuppressive therapy can effectively treat these rare, treatable intracranial complications.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Wegener's granulomatosis (WG), a form of granulomatosis with polyangiitis, is an autoimmune vasculitis.
- WG typically affects the respiratory tract and kidneys, but can have diverse systemic manifestations.
Observation:
- This report details an unusual neurologic presentation of WG.
- The patient exhibited significant meningeal and cerebral involvement.
Findings:
- The patient's condition responded well to immunosuppressive therapy.
- Intracranial complications occurred without typical WG signs (nasal/renal disease) or specific diagnostic markers (abnormal angiography, CSF pleocytosis, positive ANCA).
Implications:
- WG should be considered in neurologic presentations even without classic symptoms.
- Immunosuppressive therapy is a viable treatment for WG-related intracranial issues.
- This case highlights the importance of considering WG in unexplained central nervous system vasculitis.